Kronox Lab Sciences Limited (KRONOX) fundamentals
Kronox Lab Sciences Limited is a listed company in Chemicals & Petrochemicals, part of the Chemicals sector, listed on the NSE as KRONOX (ISIN INE0ATZ01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Kronox Lab Sciences Limited does
Kronox Lab Sciences Limited is an India-based company engaged in the manufacturing of high purity fine, inorganic chemicals, phosphate and metallic chemicals. It is a bulk manufacturer of high purity fine chemicals for the pharmaceutical, nutraceutical, veterinary, food, chemical analysis and other specialty markets. The Company offers a line of chemicals including acetates, carbonates, chlorides, citrates, nitrates, nitrites, phosphates, sulfates, and ultrapure metallic salts. The Company’s product range includes ACS Reagent, LR, AR and GR Reagents, Oral Care, Pharmacopoeia, Food and Nutraceutical, Personal Care and Cosmetics, Veterinary Pharma and Animal Health, Tartrates, Citrates, Hypophosphites, Phosphates, Hydroxides, Ethylenediaminetetraacetic acid (EDTA) and Derivatives, Ultra High Purity Chemicals, Custom Specification, and Specialty Anhydrous. It manufactures high purity specialty fine chemicals of various grades in particle sizes ranging from 10 mesh to 100 mesh.
Valuation and market data
| Last close | ₹173.00 |
|---|---|
| Market capitalisation | ₹638 crore |
| Enterprise value | ₹636 crore |
| P/E (TTM) | 23.07 |
| Price to book | 5.49 |
| Price to sales (TTM) | 3.47 |
| Book value per share | ₹31.49 |
| Dividend yield | 0.00% |
| Sector | Chemicals |
| Industry | Chemicals & Petrochemicals |
| Listed since | Mon Jun 10 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹106 crore | ₹37 crore | ₹28 crore | 7.50 |
| Mar 2025 | ₹103 crore | ₹34 crore | ₹25 crore | 6.90 |
| Mar 2024 | ₹91 crore | ₹29 crore | ₹21 crore | 5.81 |
| Mar 2023 | ₹98 crore | ₹22 crore | ₹16 crore | 4.29 |
| Mar 2022 | ₹83 crore | ₹18 crore | ₹14 crore | 3.49 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 74.2% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 2.1% |
| Retail and others | 23.7% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.